Fanucci Marsha
Insider CIK 1298814 · ALNY Director · MNTA Director · IRWD Director · FMTX Director · SYRS Director · CYCN Director · GENB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GENB Generate Biomedicines, Inc | A Award deriv | 2026-02-26 | 2026-03-02 | 29,561 | — | $0 | 29,561 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 16,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-05-18 | 2023-05-19 | 3,454 | — | $0 | 3,454 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-02-23 | 2023-02-27 | 136 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-02-23 | 2023-02-27 | 136 | — | $0 | 136 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 14,026 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 28,053 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 17,533 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | U Tender | 2022-10-14 | 2022-10-14 | 52,532 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2022-06-14 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 59,782 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-05-18 | 2022-05-20 | 5,153 | — | $0 | 5,153 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 136 | — | $0 | 136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-07-15 | 2021-07-19 | 4,032 | — | $0 | 4,032 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2021-06-24 | 2021-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 55,282 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-07-01 | 2020-07-06 | 4,581 | — | $0 | 4,581 | SEC↗ |
| FMTX Forma Therapeutics Holding | P Buy | 2020-06-23 | 2020-06-24 | 52,532 | — | $0 | 52,532 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 33,781 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 9,847 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 10,240 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 14,026 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2020-06-16 | 2020-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-11 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-11-20 | 2019-11-22 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-11-20 | 2019-11-22 | 30,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-11-20 | 2019-11-22 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-11-20 | 2019-11-22 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-11-20 | 2019-11-22 | 75,000 | $100.00 | $7.50M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-11-20 | 2019-11-22 | 15,000 | $30.09 | $451.4K | 75,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-11-20 | 2019-11-22 | 15,000 | $11.33 | $169.9K | 60,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-11-20 | 2019-11-22 | 15,000 | $9.30 | $139.5K | 45,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-11-20 | 2019-11-22 | 30,000 | $9.14 | $274.2K | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-07-01 | 2019-07-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-06-11 | 2019-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2019-06-01 | 2019-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | D To issuer | 2019-04-01 | 2019-04-03 | 4,056 | — | $0 | 132,663 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award | 2019-04-01 | 2019-04-03 | 13,671 | — | $0 | 13,671 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award | 2019-04-01 | 2019-04-03 | 3,279 | — | $0 | 16,950 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award | 2019-04-01 | 2019-04-03 | 13,671 | — | $0 | 13,671 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award | 2019-04-01 | 2019-04-03 | 3,279 | — | $0 | 16,950 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | J Other | 2018-12-31 | 2019-01-03 | 44,863 | — | $0 | 136,719 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | J Other | 2018-12-31 | 2019-01-03 | 44,863 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-06-20 | 2018-06-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-06-14 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2018-05-31 | 2018-06-04 | 16,223 | — | $0 | 91,856 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-09-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-06-02 | 2017-06-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2017-05-31 | 2017-06-02 | 15,625 | — | $0 | 75,633 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2016-09-15 | 2016-09-19 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2016-06-23 | 2016-06-27 | 11,000 | — | $0 | 11,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award | 2016-06-23 | 2016-06-27 | 5,500 | — | $0 | 14,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-06-03 | 2016-06-07 | 11,250 | — | $0 | 11,250 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2016-06-01 | 2016-06-03 | 23,674 | — | $0 | 60,008 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2015-06-10 | 2015-06-11 | 17,750 | — | $0 | 176,350 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2015-06-03 | 2015-06-05 | 16,556 | — | $0 | 36,334 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-06-01 | 2015-06-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2015-03-18 | 2015-03-20 | 31,339 | $15.68 | $491.4K | 19,778 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-02-25 | 2015-02-27 | 700 | $107.36 | $75.2K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-02-25 | 2015-02-27 | 3,025 | $106.72 | $322.8K | 700 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-02-25 | 2015-02-27 | 2,621 | $105.66 | $276.9K | 3,725 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-02-25 | 2015-02-27 | 3,654 | $104.83 | $383.0K | 6,346 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2014-06-12 | 2014-06-13 | 17,750 | — | $0 | 158,600 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-06-05 | 2014-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2014-06-03 | 2014-06-05 | 19,778 | — | $0 | 51,117 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2014-01-02 | 2014-01-03 | 9,339 | — | $0 | 31,339 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2013-06-11 | 2013-06-13 | 17,750 | — | $0 | 140,850 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2013-03-15 | 2013-03-18 | 38,400 | $8.50 | $326.4K | 123,100 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-18 | 29,400 | $14.15 | $416.0K | 9,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2012-06-21 | 2012-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2012-06-13 | 2012-06-15 | 17,750 | — | $0 | 161,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2012-02-21 | 2012-02-23 | 10,000 | $10.75 | $107.5K | 10,000 | SEC↗ |